V
Valérie Bernard
Researcher at Université Paris-Saclay
Publications - 24
Citations - 795
Valérie Bernard is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 9, co-authored 16 publications receiving 524 citations. Previous affiliations of Valérie Bernard include University of Paris-Sud & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
New insights in prolactin: pathological implications.
TL;DR: The role of prolactin in human pathophysiology is focused on, particularly the discovery of the mechanism underlying infertility associated with hyperprolactinaemia and the identification of the first mutation in human PRLR.
Journal ArticleDOI
Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome
Valérie Bernard,Bruno Donadille,Delphine Zenaty,Carine Courtillot,Sylvie Salenave,Aude Brac de la Perriere,Frédérique Albarel,Anne Fèvre,Véronique Kerlan,Thierry Brue,Brigitte Delemer,Françoise Borson-Chazot,Jean-Claude Carel,Philippe Chanson,Juliane Leger,Philippe Touraine,Sophie Christin-Maitre +16 more
TL;DR: This study suggests that pregnancy outcomes in SPs are more favourable than those after oocyte donation in TS patients, however, the risk of fetal chromosomal abnormalities remains high.
Journal ArticleDOI
Prolactin - a pleiotropic factor in health and disease.
TL;DR: This Review focuses on the newly discovered roles of prolactin in human health and disease, particularly its involvement in metabolic homeostasis including body weight control, adipose tissue, skin and hair follicles, pancreas, bone, the adrenal response to stress, the control of lactotroph cellHomeostasis and maternal behaviour.
Journal ArticleDOI
Identification of Multiple Gene Mutations Accounts for a new Genetic Architecture of Primary Ovarian Insufficiency
Justine Bouilly,Isabelle Beau,Sara Barraud,Valérie Bernard,K. Azibi,Jérôme Fagart,Anne Fèvre,Anne-Laure Todeschini,Reiner A. Veitia,Cherif Beldjord,Brigitte Delemer,Catherine Dodé,Jacques Young,Jacques Young,Nadine Binart +14 more
TL;DR: Digenic findings in several cases suggest that POI is not a purely monogenic disorder and points to a role of digenicity, and a synergistic effect of several mutations may underlie the POI phenotype.
Journal ArticleDOI
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
Valérie Bernard,Catherine Lombard-Bohas,Marie-Caroline Taquet,François-Xavier Caroli-Bosc,Philippe Ruszniewski,Patricia Niccoli,Rosine Guimbaud,Cecile N Chougnet,Bernard Goichot,Vincent Rohmer,Françoise Borson-Chazot,Eric Baudin +11 more
TL;DR: Everolimus appears to be a new effective treatment for patients with metastatic insulinoma and refractory hypoglycemia, and Tolerance should be carefully monitored.